Winston & Strawn

Site Search

Professionals (242)
Capabilities (77)
Experience (9)
Insights & News (2,163)
Other Results (98)

Professionals 242 results

Monica Lopez-Rodriguez

Of Counsel

Miami

+1 305-910-0501

vCard

Of Counsel

Miami

Yulia Makarova

Partner of Winston & Strawn London LLP

London

+44 20 7011 8803

vCard

Partner of Winston & Strawn London LLP

London

Alessandra Swanson

Partner

Chicago

+1 312-558-7435

vCard

Partner

Chicago

View All Professionals

Capabilities 77 results

Practice Area

Financial Innovation & Regulation

Winston’s Financial Innovation & Regulation attorneys routinely counsel financial services, digital assets, and other clients on complex banking, crypto, FinTech, consumer financial, and securities matters. Many of our team members previously held positions as in-house counsel at global financial institutions and served in positions at government agencies, which gives us considerable experience in helping our clients obtain innovative, effective, and efficient solutions....Read more

Practice Area

Privacy: Regulated Personal Information (RPI)

Winston’s Regulated Personal Information (RPI) Practice offers seamlessly integrated counseling and litigation services to companies looking for practical and solution-oriented assistance navigating the compliance, regulatory, and private class action enforcement risks presented by the emerging patchwork of complex (and often conflicting) privacy laws in the United States and beyond....Read more

Practice Area

Corporate Governance

Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies....Read more

Experience 9 results

Experience

March 18, 2025

Winston Blunts Earnout Payment

Following a bench trial in Fall 2024, a New York trial court ruled in March 2025 that Cresco Labs, Inc. was not required to pay a US$45M earnout under a merger agreement. The court found that Cresco did not receive “commercially reasonable access” to New York’s adult-use cannabis market, which was supposed to be subject only to a non-competitive application or approval process. Adopting Cresco’s arguments, the court determined that only the Office of Cannabis Management and Cannabis Control Board could decide when and how applicants access the adult-use market. The court agreed that regulators required Cresco to pay a significant one-time fee, prioritized other applicants, and had broad discretion over approvals. This win supports claims that New York’s adult-use program lacks details and clear entry paths, frustrating industry leaders’ efforts to develop a robust adult-use market....Read more

Experience

February 10, 2025

US$600 million Total Play Telecomunicaciones S.A.P.I. de C.V. Offer to Exchange Senior Notes

Winston & Strawn represented Total Play Telecomunicaciones, S.A.P.I. de C.V. (“Total Play”), a leading telecommunications company in Mexico, in connection with the offer to exchange (a) up to US$600M of its outstanding 6.375% Senior Notes due 2028 (the “Existing Notes”) for newly issued 11.125% Senior Secured Notes due 2032 (the “New Notes”) and (b) a cash payment by each tendering holder of U.S.$450 for each U.S.$1,000 in Existing Notes tendered by such holder (the “New Money Deposits”) for newly issued New Notes. Total Play also solicited holders for their consent to certain proposed amendments to the Existing Notes. The issuance of the New Notes was issued pursuant to Rule 144A under the Securities Act and outside the United States pursuant to Regulation S under the Securities Act....Read more

Experience

May 10, 2024

Winston Establishes the Enforceability of Keepwell Bonds in Significant Hong Kong Court of Appeal Victory

Winston’s London Restructuring practice scores a significant win on appeal for Hong Kong and BVI liquidator claimants in the People’s Republic of China (PRC) based Peking University Founders Group Limited (PUFG) insolvency. ...Read more

View All Experience

Insights & News 2,163 results

Capital Markets & Securities Law Watch

September 25, 2025

5 Min Read

SEC Issues Policy Statement on Mandatory Arbitration Provisions and Acceleration of Registration Statement Effectiveness

On September 17, 2025, the Securities and Exchange Commission (SEC or the Commission) released a policy statement (the Policy Statement) addressing its approach to mandatory arbitration provisions in the governing documents of companies intending to go public (each, an Issuer).

Client Alert

September 23, 2025

2 Min Read

FinCEN Issues Proposed Rule to Delay the Investment Adviser AML Rule by Two Years

Last month, we published an alert about the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) order providing exemptive relief for covered investment advisers from certain anti-money laundering and combating the financing of terrorism program and other Bank Secrecy Act-related reporting, recordkeeping and information-sharing obligations (IA AML Rule) until January 1, 2028. The IA AML Rule, published by FinCEN as a final rule on September 4, 2024, is currently set to become effective on January 1, 2026.
On September 22, 2025, FinCEN published a notice of proposed rulemaking to amend the IA AML Rule to delay its effective date by two years, from January 1, 2026 to January 1, 2028.

Direct Sellers Update: Regulation, Law & Policy

September 23, 2025

2 Min Read

Direct Seller Defeats Class Certification in Misclassification Case

As we’ve written previously, direct selling companies are facing a wave of lawsuits, primarily in California, claiming that distributors do not qualify as independent contractors and instead are misclassified employees. Just recently, however, a California court refused to certify a class on these claims—an important outcome for all direct sellers.

View All Insights & News

Other Results 98 results

Site Content

What Is the Federal Acquisition Regulation (FAR)?

The Federal Acquisition Regulation, commonly referred to as “FAR,” is a collection of regulations governing the process by which the federal government purchases products, supplies, and services. The FAR consists of 53 parts, each covering a different aspect of the government procurement process. FAR part 52, for example, provides solicitation provisions and clauses that can (and in some instances must) be inserted into contracts with the government. While the FAR applies to all executive agencies, many agencies, such as the Departments of Defense, State, and Veterans Affairs, have issued their own supplements to the FAR which provide regulatory guidance on contracting issues that are unique to them....Read more

Law Glossary

What Is the General Data Protection Regulation (GDPR) Law?

The European Union General Data Protection Regulation (GDPR) law is an act, applied across the Union, which directs data privacy. The GDPR law is designed to protect the data privacy of all EU citizens and guide organizational approaches to handling data, as well as transferring it across borders. Under the GDPR, breach notification is mandatory within 72 hours if the breach is likely to “result in a risk for the rights and freedoms of individuals.” The GDPR applies to organizations within the EU as well as those outside of the EU if they offer goods or services to European citizens. It also applies to organizations that monitor the behavior of data subjects online....Read more

Law Glossary

What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?

Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262....Read more